Chymosin Market

By Source;

Animal-Derived Chymosin, Microbial Chymosin, Fermentation-Produced Chymosin (FPC) and Others

By Form;

Liquid, Powder, Tablet and Others

By Application;

Cheese Production (Hard Cheese, Soft Cheese and Semi-Hard Cheese), Dairy Processing, Laboratory & Research Use and Others

By End-User;

Dairy Manufacturers, Food & Beverage Companies, Research & Academic Institutes and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn319227256 Published Date: October, 2025 Updated Date: November, 2025

Chymosin Market Overview

Chymosin Market (USD Million)

Chymosin Market was valued at USD 27,878.84 million in the year 2024. The size of this market is expected to increase to USD 38,450.46 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.

The Chymosin Market is evolving as a critical component in dairy processing due to its efficiency in curdling and enhancing cheese quality. The adoption of chymosin enzymes has surged by over 45%, driven by their superior consistency and purity compared to traditional rennet. This shift reflects growing industry preference for reliable and high-performing enzymes.


Chymosin Market

*Market size in USD million

CAGR 4.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.7 %
Market Size (2024)USD 27,878.84 Million
Market Size (2031)USD 38,450.46 Million
Market ConcentrationHigh
Report Pages357
27,878.84
2024
38,450.46
2031

Major Players

  • Chr. Hansen Holding A/S
  • DSM Food Specialties
  • DowDuPont Inc.
  • Sacco S.r.l.
  • Biocon Limited
  • Amano Enzyme Inc.
  • Advanced Enzyme Technologies Ltd.
  • Biocatalysts Ltd.
  • Enmex S.A. de C.V.
  • Clarion Casein Ltd.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Chymosin Market

Fragmented - Highly competitive market without dominant players


Growth Drivers
Increasing cheese consumption and expanding dairy product portfolios are fueling demand. Nearly 50% of producers now utilize microbial and recombinant chymosin for better cost efficiency and higher yields. Enhanced digestibility and low allergenic potential make it a choice for functional and specialty dairy items.

Technological Advancements
Advances in fermentation techniques and recombinant DNA technology are improving enzyme activity and stability. Roughly 40% of production employs recombinant methods, ensuring consistent quality and scalability. These technologies also reduce contaminants, meeting rigorous quality compliance requirements.

Market Applications
While cheese manufacturing remains the primary use, chymosin is increasingly applied in infant nutrition and dietary supplements. About 35% of specialty dairy offerings now integrate chymosin for better texture and taste. Its precise enzymatic behavior is key for premium and processed dairy products.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Source
    2. Market Snapshot, By Form
    3. Market Snapshot, By Application
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Chymosin Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Vegetarian and Halal-Certified Products
        2. Cheese Production Innovations
        3. Health-Conscious Consumers
      2. Restraints
        1. Regulatory Constraints
        2. Availability of Substitutes
        3. Cost and Production Challenges
      3. Opportunities
        1. Specialty Cheese Demand
        2. Emerging Market Expansion
        3. Technological Advancements
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Chymosin Market, By Source, 2021 - 2031 (USD Million)
      1. Animal-Derived Chymosin
      2. Microbial Chymosin
      3. Fermentation-Produced Chymosin (FPC)
      4. Others
    2. Chymosin Market, By Form, 2021 - 2031 (USD Million)
      1. Liquid
      2. Powder
      3. Tablet
      4. Others
    3. Chymosin Market, By Application, 2021 - 2031 (USD Million)
      1. Cheese Production
        1. Hard Cheese
        2. Soft Cheese
        3. Semi-Hard Cheese
      2. Dairy Processing
      3. Laboratory & Research Use
      4. Others
    4. Chymosin Market, By End-User, 2021 - 2031 (USD Million)
      1. Dairy Manufacturers
      2. Food & Beverage Companies
      3. Research & Academic Institutes
      4. Others
    5. Chymosin Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Chr. Hansen Holding
      2. DSM
      3. DuPont
      4. Sacco
      5. Clarion Casein
      6. Clover Fonterra Ingredients
      7. Aumgene Biosciences
      8. Enzyme Solutions
      9. Brenntag
      10. Miyoshi Oil & Fat
      11. Mayasan
      12. Calza Clemente
      13. International Flavors & Fragrances (IFF)
      14. Intermak
      15. Punature Food Ingredient
  7. Analyst Views
  8. Future Outlook of the Market